TegoScience Inc (KQ:191420) — Market Cap & Net Worth
Market Cap & Net Worth: TegoScience Inc (191420)
TegoScience Inc (KQ:191420) has a market capitalization of $40.93 Million (₩60.40 Billion) as of June 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #22681 globally and #1460 in its home market, demonstrating a -5.20% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying TegoScience Inc's stock price ₩7480.00 by its total outstanding shares 8074630 (8.07 Million). Review TegoScience Inc (191420) total liabilities to assess the company's total debt and financial obligations.
TegoScience Inc Market Cap History: 2015 to 2026
TegoScience Inc's market capitalization history from 2015 to 2026. Data shows change from $73.87 Million to $40.93 Million (-5.74% CAGR).
Index Memberships
TegoScience Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$270.08 Billion | 0.02% | #719 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$270.08 Billion | 0.02% | #719 of 1384 |
Weight: TegoScience Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
TegoScience Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how TegoScience Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.02x
TegoScience Inc's market cap is 0.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $138.99 Million | $8.34 Billion | $771.74 Million | 0.02x | 0.18x |
| 2017 | $273.33 Million | $8.64 Billion | -$6.02 Billion | 0.03x | N/A |
| 2018 | $194.53 Million | $7.85 Billion | -$1.83 Billion | 0.02x | N/A |
| 2019 | $128.32 Million | $6.35 Billion | $855.58 Million | 0.02x | 0.15x |
| 2020 | $166.35 Million | $8.79 Billion | $1.85 Billion | 0.02x | 0.09x |
| 2021 | $118.47 Million | $8.30 Billion | $139.26 Million | 0.01x | 0.85x |
| 2022 | $66.76 Million | $7.68 Billion | $264.51 Million | 0.01x | 0.25x |
| 2023 | $80.22 Million | $7.77 Billion | -$2.32 Billion | 0.01x | N/A |
| 2024 | $68.35 Million | $6.76 Billion | $3.35 Billion | 0.01x | 0.02x |
| 2025 | $89.19 Million | $5.94 Billion | -$7.01 Billion | 0.02x | N/A |
Competitor Companies of 191420 by Market Capitalization
Companies near TegoScience Inc in the global market cap rankings as of June 19, 2026.
Key companies related to TegoScience Inc by market ranking:
- Sam Chun Dang Pharm. Co. Ltd (KQ:000250): Ranked #4311 globally with a market cap of $3.82 Billion USD ( ₩5.63 Trillion KRW).
- ST Pharm Co.Ltd (KQ:237690): Ranked #7107 globally with a market cap of $1.61 Billion USD ( ₩2.37 Trillion KRW).
- NatureCell Co.Ltd (KQ:007390): Ranked #8654 globally with a market cap of $1.10 Billion USD ( ₩1.63 Trillion KRW).
- Oscotec Inc (KQ:039200): Ranked #10333 globally with a market cap of $755.10 Million USD ( ₩1.11 Trillion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #4311 | Sam Chun Dang Pharm. Co. Ltd | KQ:000250 | $3.82 Billion | ₩263000.00 |
| #7107 | ST Pharm Co.Ltd | KQ:237690 | $1.61 Billion | ₩127000.00 |
| #8654 | NatureCell Co.Ltd | KQ:007390 | $1.10 Billion | ₩30650.00 |
| #10333 | Oscotec Inc | KQ:039200 | $755.10 Million | ₩39650.00 |
TegoScience Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, TegoScience Inc's market cap moved from $73.87 Million to $ 40.93 Million, with a yearly change of -5.74%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩40.93 Million | -54.11% |
| 2025 | ₩89.19 Million | +30.50% |
| 2024 | ₩68.35 Million | -14.80% |
| 2023 | ₩80.22 Million | +20.16% |
| 2022 | ₩66.76 Million | -43.65% |
| 2021 | ₩118.47 Million | -28.78% |
| 2020 | ₩166.35 Million | +29.64% |
| 2019 | ₩128.32 Million | -34.04% |
| 2018 | ₩194.53 Million | -28.83% |
| 2017 | ₩273.33 Million | +96.65% |
| 2016 | ₩138.99 Million | +88.15% |
| 2015 | ₩73.87 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of TegoScience Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $40.93 Million USD |
| MoneyControl | $40.93 Million USD |
| MarketWatch | $40.93 Million USD |
| marketcap.company | $40.93 Million USD |
| Reuters | $40.93 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About TegoScience Inc
TegoScience Inc. produces and sells wound-healing skin cell therapy products from human epithelial cells in South Korea. The company's products include Holoderm, Kaloderm, and Rosmir. It also provides Neoderm, contract research, and Skinbank services. The company was founded in 2001 and is based in Seoul, South Korea.